{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:15:42Z","timestamp":1792289742964,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2928,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/sj.ki.5002623","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T14:47:51Z","timestamp":1192632471000},"page":"1543-1549","source":"Crossref","is-referenced-by-count":118,"title":["Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease"],"prefix":"10.1016","volume":"72","author":[{"given":"T.","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ideura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Isshiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002623_bb0010","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198512263132601","article-title":"Effect of captopril on heavy proteinuria in azotemic diabetics","volume":"313","author":"Taguma","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002623_bb0015","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002623_bb0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"RENAAL study investigators: effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002623_bb0025","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"African American study of kidney disease and hypertension study group: effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/sj.ki.5002623_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002623_bb0035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5002623_bb0040","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1038\/sj.ki.5002623_bb0045","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1291\/hypres.29.S1","article-title":"Japanese society of hypertension guidelines for the management of hypertension (JSH 2004)","volume":"29","author":"Guideline Subcommittee","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1038\/sj.ki.5002623_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1007882624572","article-title":"Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers","volume":"14","author":"Koshy","year":"2000","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1038\/sj.ki.5002623_bb0055","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1046\/j.1523-1755.1998.00912.x","article-title":"Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?","volume":"53","author":"Kloke","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002623_bb0060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Collaborative study group: renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002623_bb0065","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1523-1755.2004.00620.x","article-title":"Differential effects of calcium antagonist subclasses on markers of nephropathy progression","volume":"65","author":"Bakris","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002623_bb0070","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00004872-200205000-00035","article-title":"N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME\/SHR model","volume":"20","author":"Zhou","year":"2002","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5002623_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000085713","article-title":"The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome","volume":"101","author":"Konda","year":"2005","journal-title":"Nephron Physiol"},{"key":"10.1038\/sj.ki.5002623_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1291\/hypres.24.377","article-title":"Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis","volume":"24","author":"Rose","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1038\/sj.ki.5002623_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1291\/hypres.27.379","article-title":"Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases","volume":"27","author":"Kojima","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1038\/sj.ki.5002623_bb0090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"REIN-2 study group: blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trail","volume":"365","author":"Roggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002623_bb0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.ki.5000349","article-title":"Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria","volume":"70","author":"Katayama","year":"2006","journal-title":"Kidney Int"},{"issue":"Suppl 55","key":"10.1038\/sj.ki.5002623_bb0100","first-page":"S52","article-title":"Antihypertensive agents and renal protection: calcium channel blockers","volume":"49","author":"Saruta","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/sj.ki.5002623_bb0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0896-6273(00)81057-0","article-title":"Nomenclature of voltage-gated calcium channels","volume":"25","author":"Ertel","year":"2000","journal-title":"Neuron"},{"key":"10.1038\/sj.ki.5002623_bb0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","article-title":"Structure and regulation of voltage-gated Ca2+ channels","volume":"16","author":"Catterall","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1038\/sj.ki.5002623_bb0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/hh1901.097126","article-title":"Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels","volume":"89","author":"Hansen","year":"2001","journal-title":"Circ Res"},{"key":"10.1038\/sj.ki.5002623_bb0120","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1291\/hypres.28.1003","article-title":"Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure","volume":"28","author":"Hoshide","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1038\/sj.ki.5002623_bb0125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1681\/ASN.V1181469","article-title":"Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats","volume":"11","author":"Amann","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002623_bb0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1524-6175.2006.05569.x","article-title":"Influence of sympathetic activity on blood pressure and vascular damage evaluated by means of urinary albumin excretion","volume":"8","author":"Mena-Martin","year":"2006","journal-title":"J Clin Hypertens"},{"key":"10.1038\/sj.ki.5002623_bb0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1023\/A:1007702132210","article-title":"Moxonidine effect on microalbuminuria, thrombomodulin, and plasminogen activator inhibitor-1 levels in patients with essential hypertension","volume":"12","author":"Krespi","year":"1998","journal-title":"Cardiovasc Drug Ther"},{"key":"10.1038\/sj.ki.5002623_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1098-3597(04)80077-2","article-title":"Calcium channel blockers and the kidney","volume":"6","author":"Sica","year":"2004","journal-title":"Clin Cornerstone"},{"key":"10.1038\/sj.ki.5002623_bb0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0002-9149(97)00722-4","article-title":"Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure","volume":"80","author":"Grossman","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1038\/sj.ki.5002623_bb0150","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.165.8.947","article-title":"The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension","volume":"165","author":"Janice","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1038\/sj.ki.5002623_bb0155","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0002-8703(84)90763-4","article-title":"The prognostic significance of proteinuria: the framingham study","volume":"108","author":"Kannel","year":"1984","journal-title":"Am Heart J"},{"key":"10.1038\/sj.ki.5002623_bb0160","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/01.ASN.0000027871.86296.92","article-title":"Systolic hypertension in Europe (Syst-Eur) trial investigators: prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial","volume":"13","author":"de Leeuw","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 92","key":"10.1038\/sj.ki.5002623_bb0165","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1111\/j.1523-1755.2004.09221.x","article-title":"Proteinuria predicting outcome in renal disease: nondiabetic nephropathies (REIN)","volume":"66","author":"Remuzzi","year":"2004","journal-title":"Kidney Int Suppl"},{"issue":"Suppl 92","key":"10.1038\/sj.ki.5002623_bb0170","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1111\/j.1523-1755.2004.09227.x","article-title":"Framingham score and microalbuminuria: combined future targets for primary prevention?","volume":"66","author":"Asselbergs","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/sj.ki.5002623_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ajkd.2005.10.013","article-title":"Timed urine collections are not needed to measure urine protein excretion in clinical practice","volume":"47","author":"Shidham","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002623_bb0180","first-page":"110","article-title":"Quantitation of proteinuria in kidney transplant patients: accuracy of the urinary protein\/creatinine ratio","volume":"43","author":"Steinhauslin","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5002623_bb0185","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00007890-200110270-00021","article-title":"The urine protein to creatinine ratio (P\/C) as a predictor of 24-hour urine protein excretion in renal transplant patients","volume":"72","author":"Torng","year":"2001","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002623_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/00365510600608563","article-title":"Comparison between 24-h proteinuria, urinary protein\/creatinine ratio and dipstick test in patients with nephropathy: patterns of proteinuria in dipstick-negative patients","volume":"66","author":"Gai","year":"2006","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1038\/sj.ki.5002623_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.ajkd.2005.10.014","article-title":"Timed urine collections are not needed to measure urine protein excretion in clinical practice","volume":"47","author":"Gaspari","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002623_bb0200","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1373\/clinchem.2005.049742","article-title":"Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review","volume":"59","author":"Price","year":"2005","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5002623_bb0205","first-page":"S93","article-title":"DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and strafication: guideline 5. Assessment of proteinuria","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815526033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815526033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T21:54:56Z","timestamp":1629928496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815526033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0085253815526033"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002623","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}